Nasdaq Combined Compos (COMPX.US)

Cours de clôture: 17 166.00 (+457.99), 24. avr 2025
Positif

Bas risk

Automatic technical analysis. Moyen terme, 24. avr 2025

Nasdaq Combined Composite Index a débordé le plancher du canal haussier, ce qui dans un premier temps, indique un taux de croissance plus faible. Le titre a franchi un niveau de résistance sur le court terme et la stratégie de trading range court terme a donné un signal d'achat. L'indice rencontre du support à environ 16300 points et de la résistance à environ 18600 points. Le RSI diverge positivement par rapport au prix, ce qui indique l'arrivée éventuelle d'un mouvement haussier. L'indice est généralement considéré comme positif technique pour moyen long terme.

Recommendation one to six months: Positif (Score: 54)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-0.98%0.00+2.74%
5 jours0.003.24%0.00+5.27%
22 jours0.008.01%0.00-5.62%
66 jours0.0015.59%0.00-12.55%

More analyses of Nasdaq Combined Composite Index

chart Nasdaq Combined Composite Index (COMPX) Chandeliers 22 Days
Candlesticks
chart Nasdaq Combined Composite Index (COMPX) Court terme
Court terme: Négatif
chart Nasdaq Combined Composite Index (COMPX) Moyen terme
Moyen terme: Positif
chart Nasdaq Combined Composite Index (COMPX) Long terme
Long terme : Positif
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.